In this study, all GLP-1 RA treatments resulted in a significant reduction in average BG over the course of the study, whereas untreated PBS controls experienced no significant change in average BG ( Figure 5AB )
Simultaneously, the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) became operational on January 1, 2026, requiring Medicare Advantage, Medicaid, and CHIP plans to streamline PA with shorter decision timelines (72 hours for expedited, 7 days for standard) and begin publicly reporting PA metrics ( [16] )
Short-acting GLP-1 agonists like exenatide (taken twice daily) may produce more immediate effects on post-meal glucose levels, whilst longer-acting weekly formulations such as semaglutide or dulaglutide provide more sustained action but may take longer to reach steady-state concentrations in the body
Individual results vary based on diet, lifestyle, and overall health
And if you're new to Ozempic or Wegovy, your first two months of treatment will cost just $199 per month